Important Information to Know About Ongoing Negotiations and Strike Notice — Read More

Rady Children's Specialists

Respiratory Distress Syndrome (RDS)

Respiratory distress syndrome (RDS) is a prevalent issue encountered by premature infants, often leading to difficulties in breathing. Various factors can contribute to breathing problems in these infants, with RDS being the most frequent culprit.

Symptoms of Respiratory Distress Syndrome (RDS)

The symptoms of respiratory distress include:

  • Rapid breathing (tachypnea), or stopped breathing (apnea)
  • Grunting noises, nasal flaring, or pulling of the chest or neck muscles as the infant works to breathe
  • Pale color (pallor) or blue color (cyanosis)

Prevention and Treatment Respiratory Distress Syndrome (RDS)

Premature infants are highly vulnerable to respiratory distress syndrome (RDS), making prevention of premature birth a crucial approach to minimize the risk. When premature delivery cannot be prevented, healthcare providers often prescribe steroid medications to expectant mothers before delivery to reduce the severity of RDS.
After birth, infants may require surfactant medication delivered directly into their lungs through a specialized tube. This medication addresses the lack of sufficient surfactant, which is the underlying cause of RDS. By administering surfactant medication, healthcare providers effectively treat the condition and promote optimal lung function in affected infants.
Respiratory support is another critical aspect of managing RDS in infants. Two primary methods are commonly utilized. The first is mechanical ventilation, where a breathing machine called a ventilator delivers breaths to the infant through a carefully inserted breathing tube. The second method is continuous positive airway pressure (CPAP), where a gentle flow of air is delivered through prongs placed in the infant’s nose or a mask fitted over their face. CPAP helps keep the airway open and lungs adequately inflated. The choice of support depends on the severity of RDS and the infant’s clinical condition. As the infant improves, a transition to oxygen supplementation via a nasal cannula may occur and, eventually, the need for supplemental oxygen may be eliminated. By carefully monitoring the infant’s progress and adjusting respiratory support accordingly, healthcare professionals can optimize outcomes for infants with RDS.

Management of RDS

To effectively manage respiratory distress syndrome (RDS) in infants, healthcare providers consider various factors, including the levels of oxygen and carbon dioxide in the infant’s blood. These measurements serve as indications of lung function and can be obtained through different methods. One approach involves using specialized sensors to measure oxygen and carbon dioxide levels directly through the infant’s skin. Another method entails extracting small blood samples from a thin tube, known as a catheter, inserted into a blood vessel. It’s important to note that this procedure does not cause any discomfort or pain to the infant.

Typically, an X-ray of an infant who has RDS shows:

  • Low volumes of air in the lungs (atelectatic lungs).
  • A “ground glass” or grainy appearance due to the collapsed air sacs (which look light on X-ray) next to the air in the lungs (which appears dark).
  • A “white out” appearance, or more opaque looking lungs due to increased fluid in the lungs and the collapsed alveoli, or air sacs.

The integration of blood gas measurements, X-ray findings, and the infant’s clinical status empowers clinicians to make informed decisions regarding treatment strategies. Factors such as the number of surfactant medication doses administered and the duration of breathing support, either through mechanical ventilation or continuous positive airway pressure (CPAP), are carefully considered and tailored to each infant’s needs. It’s essential to acknowledge that every infant responds uniquely to treatment interventions.

Thanks to advancements in surfactant medication, the complications related to RDS have significantly decreased, resulting in reduced time spent on ventilator support for infants with this condition. The management of RDS is a collaborative effort that capitalizes on the use of comprehensive assessment techniques and personalized care practices.

Having a premature baby can be concerning, especially when it comes to their respiratory health. Premature babies have a higher risk of experiencing respiratory distress syndrome (RDS), which can affect their breathing and oxygen levels. RDS occurs because their little lungs are not fully developed yet, making it harder for them to breathe on their own.

The good news is that there are treatments available to help your baby overcome RDS. One common treatment is surfactant therapy, which helps improve their lung function and prevent complications. Healthcare providers will closely monitor your baby’s vital signs, including their blood pressure, in case they require critical care.

It’s important for you as a parent to be vigilant and aware of any signs of respiratory distress in your premature baby. If you notice any breathing difficulties or changes in their oxygen levels, it’s crucial to seek medical attention promptly. Your healthcare provider will ensure that your baby receives the necessary support to help their lungs function properly.

Remember, you’re not alone in this journey. Reach out to your healthcare provider for guidance and support. They will be able to provide you with the necessary advice and care to ensure the well-being of your little one. Stay strong, and know that with the right medical attention and your love and care, your baby has a good chance of overcoming RDS and thriving.